Lemtrada (alemtuzumab)

pCPA File Number: 20878
Negotiation Status:
Concluded with an LOI
Indication(s):
Multiple Sclerosis, Relapsing-Remitting
Sponsor/Manufacturer:
Sanofi Genzyme Canada
CDA-AMC Project Number:
SR0405-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: